Role of innate immunity in primary graft dysfunction after lung transplantation
- 1 October 2013
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Organ Transplantation
- Vol. 18 (5), 518-523
- https://doi.org/10.1097/mot.0b013e3283651994
Abstract
Primary graft dysfunction (PGD), a form of acute lung injury after lung transplantation, has a significant impact on clinical outcomes after lung transplantation. This potentially reversible graft impairment occurs after ischemia-reperfusion injury. This review describes the expanding body of literature evaluating the central role of innate immune activation, nonadaptive responses and dysregulation in the development of PGD after lung transplant. The innate immune system, highlighted by Toll-like receptor pathways and neutrophil migration and influx, plays an important role in the initiation and propagation of ischemia-reperfusion injury. Recent plasma biomarker and gene association studies have identified several genes and proteins composing innate immune pathways to be associated with PGDs. Long pentraxin-3 and Toll-like receptors, as well as inflammasomes and Toll-interacting protein, are associated with the development of PGD after lung transplantation. Innate immune pathways are involved in the development of PGD and may provide attractive targets for therapies. It may be possible to prevent or treat PGD, as well as to allow pre-transplant PGD risk stratification. To improve understanding of the mechanisms behind clinical risk factors for PGD will require further in-depth correlation of donor-specific and recipient-related triggers of nonadaptive immune responses.Keywords
This publication has 75 references indexed in Scilit:
- Elevated Plasma Long Pentraxin-3 Levels and Primary Graft Dysfunction After Lung Transplantation for Idiopathic Pulmonary FibrosisAmerican Journal of Transplantation, 2011
- T-Cell Immunoglobulin Mucin-3 Determines Severity of Liver Ischemia/Reperfusion Injury in Mice in a TLR4-Dependent MannerGastroenterology, 2010
- Innate immunity and cardiac allograft rejectionKidney International, 2010
- In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammationProceedings of the National Academy of Sciences of the United States of America, 2010
- Receptor for Advanced Glycation End Products in Donor Lungs Is Associated with Primary Graft Dysfunction After Lung TransplantationAmerican Journal of Transplantation, 2010
- Role of neutrophils in innate immunity: a systems biology‐level approachWires Systems Biology and Medicine, 2009
- Innate immunity in heart transplantationCurrent Opinion in Organ Transplantation, 2009
- Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Late Primary Graft Dysfunction After Lung Transplantation and Bronchiolitis Obliterans SyndromeAmerican Journal of Transplantation, 2008
- Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injuryThorax, 2008